University of California: Study Confirms Safety and Efficacy of Higher-dose-per-day Radiation for Early-Stage Prostate Cancer
March 19, 2025
March 19, 2025
LOS ANGELES, California, March 19 -- The University of California issued the following news release:
* * *
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
Key takeaways
* Patients who received shorter, standard-dose course radiation treatment (MHFRT) had the same cancer control rates as those who received conventional radiotherapy.
* Those who received higher dose-escalated MHFRT . . .
* * *
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
Key takeaways
* Patients who received shorter, standard-dose course radiation treatment (MHFRT) had the same cancer control rates as those who received conventional radiotherapy.
* Those who received higher dose-escalated MHFRT . . .